{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:03:48Z","timestamp":1793714628147,"version":"4.6.1"},"reference-count":106,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Adeno-associated virus (AAV) is a non-pathogenic virus that mainly infects primates with the help of adenoviruses. AAV is being widely used as a delivery vector for in vivo gene therapy, as evidenced by five currently approved drugs and more than 255 clinical trials across the world. Due to its relatively low immunogenicity and toxicity, sustained efficacy, and broad tropism, AAV holds great promise for treating many indications, including central nervous system (CNS), ocular, muscular, and liver diseases. However, low delivery efficiency, especially for the CNS due to the blood-brain barrier (BBB), remains a significant challenge for more clinical application of AAV gene therapy. Thus, there is an urgent need for utilizing AAV engineering to discover next-generation capsids with improved properties, e.g., enhanced BBB penetrance, lower immunogenicity, and higher packaging efficiency. AAV engineering methods, including directed evolution, rational design, and in silico design, have been developed, resulting in the discovery of novel capsids (e.g., PhP.B, B10, PAL1A\/B\/C). In this review, we discuss key studies that identified engineered CNS capsids and\/or established methodological improvements. Further, we also discussed important issues that need to be addressed, including cross-species translatability, cell specificity, and modular engineering to improve multiple properties simultaneously.<\/jats:p>","DOI":"10.3390\/biology12020186","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T01:27:58Z","timestamp":1674782878000},"page":"186","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["AAV Engineering for Improving Tropism to the Central Nervous System"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-589X","authenticated-orcid":false,"given":"Muhammad S.","family":"Ghauri","sequence":"first","affiliation":[{"name":"School of Medicine, California University of Science and Medicine, Colton, CA 92324, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ou","sequence":"additional","affiliation":[{"name":"Genemagic Biosciences, Media, PA 19086, USA"},{"name":"Department of Pediatrics, University of Minnesota, Minneapolis, MN 55454, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","article-title":"AAV-Mediated Gene Therapy for Research and Therapeutic Purposes","volume":"1","author":"Samulski","year":"2014","journal-title":"Annu. Rev. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","article-title":"Extrachromosomal Recombinant Adeno-Associated Virus Vector Genomes Are Primarily Responsible for Stable Liver Transduction In Vivo","volume":"75","author":"Nakai","year":"2001","journal-title":"J. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","article-title":"A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells","volume":"39","author":"Nguyen","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1142658","article-title":"AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma","volume":"317","author":"Donsante","year":"2007","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI79213","article-title":"Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy","volume":"125","author":"Chandler","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1001263","DOI":"10.3389\/fimmu.2022.1001263","article-title":"rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/hum.2020.217","article-title":"Re: \u201cMoving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy\u201d by Wilson and Flotte","volume":"31","author":"Shieh","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"991832","DOI":"10.3389\/fimmu.2022.991832","article-title":"A versatile toolkit for overcoming AAV immunity","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMoa2005056","article-title":"SOD1Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS","volume":"383","author":"Mueller","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/hum.2017.026","article-title":"Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41591-021-01664-4","article-title":"AAV gene therapy for Tay-Sachs disease","volume":"28","author":"Flotte","year":"2022","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.gt.3302883","article-title":"Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer","volume":"14","author":"Sevin","year":"2007","journal-title":"Gene Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1128\/JVI.74.18.8635-8647.2000","article-title":"Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism","volume":"74","author":"Wu","year":"2000","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1073\/pnas.0802866105","article-title":"Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses","volume":"105","author":"Zhong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1128\/JVI.80.2.821-834.2006","article-title":"Mutations on the External Surfaces of Adeno-AssociatedVirus Type 2 Capsids That Affect Transduction and Neutralization","volume":"80","author":"Lochrie","year":"2006","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.vaccine.2012.03.079","article-title":"High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors","volume":"30","author":"Aslanidi","year":"2012","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7752","DOI":"10.1128\/JVI.00675-12","article-title":"Single Amino Acid Modification of Adeno-Associated Virus Capsid Changes Transduction and Humoral Immune Profiles","volume":"86","author":"Li","year":"2012","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Aslanidi, G.V., Rivers, A.E., Ortiz, L., Song, L., Ling, C., Govindasamy, L., Van Vliet, K., Tan, M., Agbandje-McKenna, M., and Srivastava, A. (2013). Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059142"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/viro.1999.0045","article-title":"Insertional Mutagenesis of AAV2 Capsid and the Production of Recombinant Virus","volume":"265","author":"Rabinowitz","year":"1999","journal-title":"Virology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1128\/JVI.77.12.6995-7006.2003","article-title":"Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding","volume":"77","author":"Opie","year":"2003","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.omtn.2017.06.011","article-title":"Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS","volume":"8","author":"Kanaan","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"16026","DOI":"10.1038\/mtm.2016.26","article-title":"Microglia-specific targeting by novel capsid-modified AAV6 vectors","volume":"3","author":"Rosario","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ymgme.2010.07.008","article-title":"An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1\u03b1","volume":"101","author":"Glushakova","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biomaterials.2018.05.041","article-title":"Blood-brain barrier shuttle peptides enhance AAV transduction in the brain after systemic administration","volume":"176","author":"Zhang","year":"2018","journal-title":"Biomaterials"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41434-020-00206-w","article-title":"Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouse","volume":"28","author":"Gilkes","year":"2021","journal-title":"Gene Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41551-022-00938-7","article-title":"Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood\u2013brain barrier in rodents and primates","volume":"6","author":"Yao","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.omtm.2021.02.019","article-title":"Cell-penetrating peptides enhance the transduction of adeno-associated virus serotype 9 in the central nervous system","volume":"21","author":"Meng","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1006\/mthe.2001.0345","article-title":"Incorporation of Tumor-Targeting Peptides into Recombinant Adeno-associated Virus Capsids","volume":"3","author":"Grifman","year":"2001","journal-title":"Mol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/mt.2014.139","article-title":"Vector Design Tour de Force: Integrating Combinatorial and Rational Approaches to Derive Novel Adeno-associated Virus Variants","volume":"22","author":"Marsic","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1128\/JVI.75.4.1824-1833.2001","article-title":"Intracellular Trafficking of Adeno-Associated Virus Vectors: Routing to the Late Endosomal Compartment and Proteasome Degradation","volume":"75","author":"Douar","year":"2001","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.omtm.2018.03.004","article-title":"A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates","volume":"9","author":"Wang","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd.2018.158","article-title":"Erratum: Gene therapy for neurological disorders: Progress and prospects","volume":"17","author":"Deverman","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e120474","DOI":"10.1172\/jci.insight.120474","article-title":"Double-stranded RNA innate immune response activation from long-term adeno-associated virus vector transduction","volume":"3","author":"Shao","year":"2018","journal-title":"JCI Insight"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/brain\/awy126","article-title":"A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency","volume":"141","author":"Tordo","year":"2018","journal-title":"Brain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/mt.2012.186","article-title":"Displaying High-affinity Ligands on Adeno-associated Viral Vectors Enables Tumor Cell-specific and Safe Gene Transfer","volume":"21","author":"Janicki","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"New Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"15587","DOI":"10.1523\/JNEUROSCI.2037-14.2014","article-title":"Delayed Disease Onset and Extended Survival in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis after Suppression of Mutant SOD1 in the Motor Cortex","volume":"34","author":"Thomsen","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/hum.2015.122","article-title":"Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1G93A Mice and Nonhuman Primates","volume":"27","author":"Borel","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/mt.2013.211","article-title":"Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS","volume":"21","author":"Foust","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/hum.2013.200","article-title":"Silencing Mutant Huntingtin by Adeno-Associated Virus-Mediated RNA Interference Ameliorates Disease Manifestations in the YAC128 Mouse Model of Huntingtons Disease","volume":"25","author":"Stanek","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington\u2019s Disease Mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/nbt856","article-title":"Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors","volume":"21","author":"Kaul","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1525-0016(03)00123-0","article-title":"In vitro selection of viral vectors with modified tropism: The adeno-associated virus display","volume":"8","author":"Perabo","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1242\/dev.115253","article-title":"Enhanced selective gene delivery to neural stem cells in vivo by an adeno-associated viral variant","volume":"142","author":"Kotterman","year":"2015","journal-title":"Development"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/mt.2008.167","article-title":"DNA Shuffling of Adeno-associated Virus Yields Functionally Diverse Viral Progeny","volume":"16","author":"Koerber","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jgm.849","article-title":"Combinatorial engineering of a gene therapy vector: Directed evolution of adeno-associated virus","volume":"8","author":"Perabo","year":"2006","journal-title":"J. Gene Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nbt1182","article-title":"Directed evolution of adeno-associated virus yields enhanced gene delivery vectors","volume":"24","author":"Maheshri","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","article-title":"A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons","volume":"92","author":"Tervo","year":"2016","journal-title":"Neuron"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/mt.2016.84","article-title":"In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy","volume":"24","author":"Choudhury","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41467-022-33745-4","article-title":"Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing","volume":"13","author":"Gonzalez","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Issa, P.C., De Silva, S.R., Lipinski, D.M., Singh, M.S., Mouravlev, A., You, Q.S., Barnard, A.R., Hankins, M.W., During, M.J., and MacLaren, R.E. (2013). Assessment of Tropism and Effectiveness of New Primate-Derived Hybrid Recombinant AAV Serotypes in the Mouse and Primate Retina. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060361"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/mt.2009.292","article-title":"Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood\u2013Brain Barrier (BBB)","volume":"18","author":"Gray","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.omtm.2019.10.007","article-title":"Selection of an Efficient AAV Vector for Robust CNS Transgene Expression","volume":"15","author":"Hanlon","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41592-022-01547-7","article-title":"Directed evolution of adeno-associated virus for efficient gene delivery to microglia","volume":"19","author":"Lin","year":"2022","journal-title":"Nat. Methods"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11060-009-9972-7","article-title":"Directed evolution of adeno-associated virus for glioma cell transduction","volume":"96","author":"Maguire","year":"2009","journal-title":"J. Neuro Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gt.2017.27","article-title":"Improved gene delivery to adult mouse spinal cord through the use of engineered hybrid adeno-associated viral serotypes","volume":"24","author":"Siu","year":"2017","journal-title":"Gene Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/12491","article-title":"Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2","volume":"5","author":"Girod","year":"1999","journal-title":"Nat. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.omtm.2020.12.006","article-title":"Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning","volume":"20","author":"Nonnenmacher","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1038\/mt.2009.184","article-title":"Molecular Evolution of Adeno-associated Virus for Enhanced Glial Gene Delivery","volume":"17","author":"Koerber","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"27053","DOI":"10.1073\/pnas.1910061116","article-title":"A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism","volume":"116","author":"Davidsson","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"609","DOI":"10.15252\/emmm.201506078","article-title":"A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases","volume":"8","author":"Dogbevia","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.neuron.2022.05.003","article-title":"Engineered AAVs for non-invasive gene delivery to rodent and non-human primate nervous systems","volume":"110","author":"Chen","year":"2022","journal-title":"Neuron"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41593-021-00969-4","article-title":"AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset","volume":"25","author":"Goertsen","year":"2022","journal-title":"Nat. Neurosci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/mt.2010.287","article-title":"An Evolved Adeno-associated Viral Variant Enhances Gene Delivery and Gene Targeting in Neural Stem Cells","volume":"19","author":"Jang","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41592-020-0799-7","article-title":"Multiplexed Cre-dependent selection yields systemic AAVs for targeting distinct brain cell types","volume":"17","author":"Kumar","year":"2020","journal-title":"Nat. Methods"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL\/6J Mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Huang, Q., Chan, K.Y., Tobey, I.G., Chan, Y.A., Poterba, T., Boutros, C.L., Balazs, A.B., Daneman, R., Bloom, J.M., and Seed, C. (2019). Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. PLoS ONE, 14.","DOI":"10.1101\/538421"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Chuapoco, M.R., Flyzanis, N.C., Chan, K.Y., Arokiaraj, C.M., Miles, T.F., Jang, M.J., Vedemiatti, J., Deverman, B.E., Pickel, J., and Gradinaru, V. (2022). Intravenous gene transfer throughout the brain of infant Old World primates using AAV. bioRxiv.","DOI":"10.1101\/2022.01.08.475342"},{"key":"ref_73","first-page":"31","article-title":"Systemic administration of novel engineered AAV capsids facilitates enhanced transgene expression in the macaque CNS","volume":"4","author":"Stanton","year":"2023","journal-title":"Med. (New York, N.Y.)"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.celrep.2015.07.019","article-title":"In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector","volume":"12","author":"Zinn","year":"2015","journal-title":"Cell Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ymthe.2019.04.006","article-title":"AAV Engineering Identifies a Species Barrier That Highlights a Portal to the Brain","volume":"27","author":"Vandenberghe","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/hum.2017.154","article-title":"Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina in Vivo","volume":"29","author":"Carvalho","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1681\/ASN.2018040426","article-title":"Efficient Gene Transfer to Kidney Mesenchymal Cells Using a Synthetic Adeno-Associated Viral Vector","volume":"29","author":"Ikeda","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nbt.3781","article-title":"A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear","volume":"35","author":"Landegger","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/hum.2017.120","article-title":"Delivery of Adeno-Associated Virus Vectors in Adult Mammalian Inner-Ear Cell Subtypes Without Auditory Dysfunction","volume":"29","author":"Tao","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.omtm.2018.07.006","article-title":"Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65","volume":"10","author":"Hudry","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/gt.2015.74","article-title":"AAV ancestral reconstruction library enables selection of broadly infectious viral variants","volume":"22","author":"Ojala","year":"2015","journal-title":"Gene Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molmed.2022.01.003","article-title":"AAV capsid design: A Goldilocks challenge","volume":"28","author":"Zolotukhin","year":"2022","journal-title":"Trends Mol. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"100803","DOI":"10.1016\/j.xcrm.2022.100803","article-title":"Ancestral library identifies conserved reprogrammable liver motif on AAV capsid","volume":"3","author":"Zinn","year":"2022","journal-title":"Cell Rep. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Sinai, S., Jain, N., Church, G.M., and Kelsic, E.D. (2021). Generative AAV capsid diversification by latent interpolation. bioRxiv.","DOI":"10.1101\/2021.04.16.440236"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.aaw2900","article-title":"Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design","volume":"366","author":"Ogden","year":"2019","journal-title":"Science"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.omtm.2020.11.017","article-title":"Applying machine learning to predict viral assembly for adeno-associated virus capsid libraries","volume":"20","author":"Marques","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41587-020-00793-4","article-title":"Deep diversification of an AAV capsid protein by machine learning","volume":"39","author":"Bryant","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Zhu, D., Brookes, D.H., Busia, A., Carneiro, A., Fannjiang, C., Popova, G., Shin, D., Chang, E., Nowakowski, T., and Listgarten, J. (2022). Optimal trade-off control in machine learning-based library design, with application to adeno-associated virus (AAV) for gene therapy. bioRxiv, 2021-11.","DOI":"10.1101\/2021.11.02.467003"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molmed.2020.09.010","article-title":"Journey to the Center of the Cell: Tracing the Path of AAV Transduction","volume":"27","author":"Dhungel","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"674021","DOI":"10.3389\/fimmu.2021.674021","article-title":"Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning","volume":"12","author":"Wec","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e64175","DOI":"10.7554\/eLife.64175","article-title":"scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution","volume":"10","author":"Johnson","year":"2021","journal-title":"eLife"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"730825","DOI":"10.3389\/fimmu.2021.730825","article-title":"Deep Parallel Characterization of AAV Tropism and AAV-Mediated Transcriptional Changes via Single-Cell RNA Sequencing","volume":"12","author":"Brown","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12875","article-title":"Selection and evaluation of clinically relevant AAV variants in a xenograft liver model","volume":"506","author":"Lisowski","year":"2014","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1089\/hum.2020.167","article-title":"Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology","volume":"31","author":"Hordeaux","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"eaba9188","DOI":"10.1126\/scitranslmed.aba9188","article-title":"MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates","volume":"12","author":"Hordeaux","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1089\/hum.1998.9.13-1929","article-title":"Development of Novel Cell Surface CD34-Targeted Recombinant Adenoassociated Virus Vectors for Gene Therapy","volume":"9","author":"Yang","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fnins.2017.00503","article-title":"Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting","volume":"11","author":"Carvalho","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_98","first-page":"611","article-title":"Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes","volume":"90","author":"McClements","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/hum.2019.220","article-title":"Can Adeno-Associated Viral Vectors Deliver Effectively Large Genes?","volume":"31","author":"Tornabene","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/mt.2010.94","article-title":"Widespread Muscle Expression of an AAV9 Human Mini-dystrophin Vector After Intravenous Injection in Neonatal Dystrophin-deficient Dogs","volume":"18","author":"Kornegay","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1055\/s-0037-1616092","article-title":"A Factor VIII Minigene Comprising the Truncated Intron I of Factor IX Highly Improves the In Vitro Production of Factor VIII","volume":"86","author":"Plantier","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nbt0702-697","article-title":"Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene","volume":"20","author":"Halbert","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/mt.2010.205","article-title":"Gene Therapy of mdx Mice With Large Truncated Dystrophins Generated by Recombination Using rAAV6","volume":"19","author":"Odom","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/nbt1153","article-title":"Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors","volume":"23","author":"Lai","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4939-3271-9_2","article-title":"Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors","volume":"1382","author":"Hirsch","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1093\/hmg\/ddv386","article-title":"Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease","volume":"24","author":"Trapani","year":"2015","journal-title":"Hum. Mol. Genet."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/2\/186\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:15:57Z","timestamp":1760120157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/2\/186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":106,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["biology12020186"],"URL":"https:\/\/doi.org\/10.3390\/biology12020186","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]}}}